Navigation Links
Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
Date:1/31/2008

, net (14.4)

Other income/(expense), net (11.5)

Income before taxes 7.2

Tax expense (0.5)

NET INCOME 11.2

Net income per common share

assuming dilution 15.3%

Weighted average number of shares

Basic

Diluted

Profit Margins: Inc/(Dec) vs. prior

year profit

margin %

Gross profit (1.0%)

R&D (0.4%)

S,G&A (0.2%)

Operating income (0.4%)

Income before taxes (0.9%)

Net income (0.2%)

FREE CASH FLOW RECONCILIATION

Three Months Ended Nine Months Ended

12-29-07 12-30-06 12-29-07 12-30-06

GAAP CASH FLOW FROM OPERATIONS $24,876 $25,968 $45,754 $59,467

Capital expenditures ($15,242) ($9,695) ($42,497) ($26,985)

Proceeds from sale of property,

plant and equipment $1,187 $834 $3,149 $2,588

Net investment in property, plant

and equipment ($14,055) ($8,861) ($39,348) ($24,397)

Free Cash Flow $10,821 $17,107 $6,406 $35,070

(1) Haemonetics' Q3FY08 adjusted financial r
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results
2. Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
3. P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company
4. Nutraceutical Reports Fiscal 2008 Q1 Results
5. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
6. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
7. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
8. Encision Reports Third Fiscal Quarter Results
9. Zimmer Reports Fourth Quarter and 2007 Financial Results
10. Amylin Pharmaceuticals Reports 2007 Financial Results
11. Cystic Fibrosis Foundation reports upward trend for key health outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... iFitDress.com, the popular online supplier of wedding dresses and special ... black one-shoulder cocktail dresses . In addition, all these ... discounted prices, up to 70% off. , The ... only. You know, we have thousands of frequent callers in ... items can visit our website for more details. The current ...
(Date:12/25/2014)... CA (PRWEB) December 25, 2014 The short ... was created in honor of a true 9/11 hero, ... two film festivals including the 24 hours of Nuremberg International ... in Bangladesh. , Actress, screenwriter and director Luciana ... produce this film together with her husband, Gregory Graham ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
(Date:12/25/2014)... When head lice hits a home or school, parents ... rid of it while keeping it from taking over the ... the solution right in their neighborhood: Lice Troopers . ... full spectrum head lice screening and treatment services to families ... Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
... , moms-to-be who are carrying girls are more likely ... pregnant asthmatic women carrying boys. Doctors speculate female fetuses ... of the mother’s airways that somehow worsens the woman’s ... asthmatic women who were pregnant with boys were symptom-free ...
... full body examination be done when it comes to screening ... // in the early stages of development. But cancers arising ... back or bottom -- are often missed by patients until ... researchers who surveyed about 250 patients in dermatology or general ...
... most worrisome long-term side effects of high-dose chemotherapy, say specialists. ... that might indicate which patients are at greatest risk and ... I is a protein present only in heart cells. TNI ... that is used to diagnose and treat heart attacks and ...
... for colon cancer is as effective as open surgery. ... laparoscopically assisted surgery, has been an option. With minimally ... incisions and one two-inch incision compared to the open ... But the question has remained whether minimally invasive surgery ...
... is a blood clot that develops deep in the vein. ... lung. // ,People who require prolonged bed rest ... circulation ,especially patients in intensive care and patient on catheters ... shown that in critically ill patients , a small pulmonary ...
... stages of pregnancy seems to increase the size of the infant, ... fish // may boost the fetal growth rate during pregnancy. They ... was to deliver a low birth weight baby. ,Researchers ... pregnancies. In women who ate no fish, that rate increased to ...
Cached Medicine News:
(Date:12/24/2014)...   Synageva BioPharma Corp. (NASDAQ: ... products for rare disorders, today announced validation by ... Authorization Application (MAA) for sebelipase alfa for LAL ... for accelerated assessment, which has the potential to ... The MAA, and the Biologics License Application ...
(Date:12/24/2014)... CHENGDU, China , Dec. 23, 2014 /PRNewswire/ ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today announced that the ... for its Good Manufacturing Practice (GMP) certificate of ... & Drug Administration,s (CFDA). The public notice period ...
(Date:12/22/2014)... 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical ... purification technology to help fight deadly inflammation in ... worldwide, today announced the appointment of Dr. ... its Senior Vice President of Clinical Development, effective ... Di Russo is an accomplished pediatric cardiothoracic ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... Neuro Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of ... vestibular and neurological conditions, said today that it co-presented ... conference meeting in Scottsdale, Arizona. The research ... clinical testing that can be conducted with its medical ...
... 2011 IRIDEX Corporation (Nasdaq: IRIX ) today reported ... improved financial results for the fourth quarter ended January 1, 2011. ... per share, up from $0.5 million or $0.05 per diluted share ... to $12.2 million in the 2010 fourth quarter, up 6% from ...
Cached Medicine Technology:Neuro Kinetics Presenting New Balance & Dizziness Research at American Balance Society Conference 2IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter 2IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter 3IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter 4IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter 5